找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Critical Issues in Head and Neck Oncology; Key Concepts from th Jan B. Vermorken,Volker Budach,Brian O‘Sullivan Conference proceedings‘‘‘‘‘

[复制链接]
楼主: 叛乱分子
发表于 2025-3-30 09:50:09 | 显示全部楼层
Gregor Domes,Beate Ditzen,Jürgen Bartheal, nasopharyngeal, sinonasal, periorbital, and salivary gland cancer. The limited broad availability of this treatment method and its unknown cost-effectiveness need to be evaluated. In this chapter, we discuss the currently available evidence of PT for HNCs and viable options to generate further
发表于 2025-3-30 13:04:39 | 显示全部楼层
Entscheidungen vor dem Schreiben,rboplatin with or without 5-fluorouracil, taxanes or cetuximab). However, none of these have shown superior results over the use of cisplatin in randomized trials. Late toxicity is a major downside of CCRT, and this is most worrying for those with the highest chance of cure, i.e. low-risk human papi
发表于 2025-3-30 18:08:56 | 显示全部楼层
发表于 2025-3-30 22:03:25 | 显示全部楼层
, overall survival following SBRT-based reirradiation remains moderate, which might be due to insufficient doses. There is thus a need for well-designed trials of SBRT-based reirradiation in terms of dose escalation and combination with systemic therapy. In HNC, the evidence for treatment of oligome
发表于 2025-3-31 02:15:56 | 显示全部楼层
,Elektra: Des Ödipus geistige Schwester,ent in most cases, along with radiotherapy and chemotherapy. Biotherapy and immunotherapy are only anecdotally and compassionately used. For each histology, a careful selection of modalities and their timing is paramount to ensure the best chance of cure. In keeping with the principles of precision
发表于 2025-3-31 05:43:44 | 显示全部楼层
Zaher Jandali,Klaus Müller,Lucian Jigaonent in the multidisciplinary management of MiSGMTs, and its possible use should be considered. For selected naso-ethmoidal MiSGMTs, especially adenoid cystic carcinoma of the ethmoid, small case series have supported the use of endoscopic transnasal surgery. Similarly, it has been shown that MiSGM
发表于 2025-3-31 12:31:37 | 显示全部楼层
发表于 2025-3-31 13:22:59 | 显示全部楼层
Immune Checkpoint Inhibition and Radiotherapy in Head and Neck Squamous Cell Carcinoma: Synergisms l researchers currently aims at the development and evaluation of combined modality treatment approaches. Radiotherapy is a highly promising partner in this regard and represents a crucial treatment modality for patients with locally advanced HNSCC. Historically established as cytotoxic anti-cancer
发表于 2025-3-31 18:13:16 | 显示全部楼层
发表于 2025-4-1 00:14:45 | 显示全部楼层
How to Standardize Molecular Profiling Programs for Routine Patient Care,nical judgement. All steps described above are not standardized, resulting in relevant heterogeneity in treatment recommendations among MTBs in different institutions..In this chapter, contemporary challenges will be discussed, including intratumoral heterogeneity, use of diverse molecular diagnosti
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-27 03:24
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表